CoChat

Matrix mechanical remodeled carrier-free nanosystem for programmable closed-loop reversal of liver fibrosis via STING alkylation

Open access
Han, Hongyun, Yu, Dongrun, Liu, Yuxiang, Jia, Huizhen, Liu, Wenguang · 2025 · Science Advances

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index; 23 of the 36 sources its claims cite were checked for support.

Abstract

Extracellular matrix (ECM) sclerosis represents a prominent feature of fibrotic disorders; however, the macrophage response to changes in matrix stiffness and its impact on fibrotic diseases remain unclear. This study reveals a vicious circle of ECM-cell-ECM, where increased ECM hardness activates the STING pathway in macrophages, in turn activates hepatic stellate cells (HSCs), thus enhancing ECM stiffness again and exacerbating liver fibrosis. To reverse liver fibrosis, an innovative carrier-free nanosystem capable of degrading ECM, specifically blocking the STING pathway in macrophages as well as remodeling matrix mechanical, is created. In mouse models, pharmacological STING inhibition via alkylation in macrophages, combined with ECM degradation via matrix metalloproteinases and metal ion-induced macrophage polarization, reduces stromal stiffness and reverses fibrosis. Our findings underscore the antifibrotic potential of matrix mechanical remodeling, demonstrating that concurrent reduction of matrix stiffness and inhibition of STING pathway in macrophages can synergistically promote fibrosis regression. This research establishes a previously unidentified paradigm for liver fibrosis reversal.

Overview

CoChat Summary

## TL;DR

The paper argues that liver fibrosis is sustained by an ECM-cell-ECM vicious cycle in which increased matrix stiffness activates macrophage STING signaling, which then drives HSC activation and further ECM stiffening. The authors built a carrier-free nanosystem (ICMA@CZ) to degrade ECM, target macrophages, and inhibit STING, and report that it reversed fibrosis in mice.

## Key findings

  • In GelMA hydrogels spanning 0.1 to 5 kPa, macrophages showed stiffness-dependent responses: Ca2+ increased ~15-fold in 30% GelMA (5 kPa) versus initial cells, mitochondrial membrane potential dropped, and p-STING, p-TBK1, p-IRF3, plus TNF-α, IFN-β, and IL-6, increased with stiffness.
  • In transwell/conditioned-medium experiments, ICMA@CZ degraded collagen better than ICMA: macrophage fluorescence was 5 to 10 times higher than ICMA in 15% and 30% hydrogel conditions, and HSC α-SMA fluorescence was ~3 to 4-fold lower than in activated HSC-T6 cells.
  • The nanosystem showed homotypic macrophage targeting: MM-coated nanoparticles had ~8 to 9-fold higher uptake in RAW 264.7 cells and ~10 to 12-fold higher uptake in Kupffer cells than in HSCs; the carrier-free system had ~96% 4-OI loading efficiency.
  • In the mouse fibrosis model, ICMA@CZ reduced serum ALT/AST, lowered collagen staining by sevenfold toward control levels, reduced liver stiffness toward normal, and nearly normalized p-STING-positive cells; it also reduced TNF-α (fivefold), IFN-β (fivefold), IL-6 (eightfold), and TGF-β (sevenfold) in liver tissue.

## Methods

  • The study combined in vitro mechanistic assays with an in vivo CCl4-induced alcohol-associated liver disease (AALD) / moderate liver fibrosis mouse model.
  • GelMA hydrogels were used to create matrix stiffness conditions (0.1 to 5 kPa) for RAW 264.7 macrophages; readouts included Rhod-2 AM Ca2+ staining, JC-1 mitochondrial membrane potential, Western blotting, ELISA, flow cytometry, immunofluorescence, and collagen assays.
  • The nanosystem was assembled stepwise as 4-OI/ICG (IC) → macrophage membrane-coated (ICM) → AP-modified (ICMA) → CZ-loaded (ICMA@CZ), and evaluated by DLS, TEM, HPLC, transwell penetration, confocal microscopy, and in vivo biodistribution/antifibrosis testing.

## Limitations

  • The paper does not state explicit study limitations in the provided text.
  • Evidence of effectiveness is largely from cell culture and mouse models; any limitation about human translation is not stated in the paper but is evident from the text.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1126/sciadv.adz4126

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1. Nanosystem design and programmed closed-loop reversal of liver fibrosis. (A) Preparation of MMs and matrix mechanics remodeled carrier-free nanosystem (ICMA@CZ) by packing the 4-OI and ICG coassembly nanoparticles with MMs modified with matrix metalloproteinase (CZ). (B) Schematic illustration of macrophage homologous targeting the carrier-free nanosystem loaded with CZ to degrade ECM efficiently while in parallel released 4-OI to block the STING pathway in macrophage, combining Zn2+ to regulate the polarization of macrophages and remodel the matrix mechanics to achieve a programmed closed-loop reversal of liver fibrosis through modulating the ECM-cell-ECM circuit. aHSC, activated hepatic stellate cells. NPs, nanoparticles.
Fig. 1. Nanosystem design and programmed closed-loop reversal of liver fibrosis. (A) Preparation of MMs and matrix mechanics remodeled carrier-free nanosystem (ICMA@CZ) by packing the 4-OI and ICG coassembly nanoparticles with MMs modified with matrix metalloproteinase (CZ). (B) Schematic illustration of macrophage homologous targeting the carrier-free nanosystem loaded with CZ to degrade ECM efficiently while in parallel released 4-OI to block the STING pathway in macrophage, combining Zn2+ to regulate the polarization of macrophages and remodel the matrix mechanics to achieve a programmed closed-loop reversal of liver fibrosis through modulating the ECM-cell-ECM circuit. aHSC, activated hepatic stellate cells. NPs, nanoparticles.CC BY · PubMed Central
Fig. 2. Reveal of the ECM-cell-ECM vicious circle. (A) Mechanical strength and photograph of liver tissues with/without liver fibrosis. (B) Three-dimensional surface plots display surface hardness uniformity of hydrogels. (C) The response of macrophages to changes in matrix stiffness through a cycle of ECM-cell-ECM. Mechanism mechanics induce influx of Ca2+, mitochondrial damage, STING pathway activation, secretion of proinflammatory factors, HSC activation, and further resulting enhancement of matrix stiffness. (D) Approach to model the in vitro matrix mechanical environment. (E) Microphotographs of intracellular Ca2+ production of RAW 264.7 cells after treatments with various concentrations of GelMA hydrogel for 24 hours and (F) mean fluorescence intensity (MFI) of intracellular Ca2+ were analyzed using ImageJ software. (G) Mitochondrial membrane potentials of RAW 264.7 cells treated with various concentrations of GelMA hydrogel for 24 hours and (H) MFI of mitochondrial membrane potentials in RAW 264.7 were analyzed using ImageJ software. (I) Western blot detection of STING, TBK1, IRF3, p-STING, p-TBK1, and p-IRF3 in RAW 264.7 cells subjected to various concentrations of GelMA hydrogel treatments. (J) ELISA assay for extracellular secretion of TNF-α, IL-6, and IFN-β by RAW 264.7 cells at 24 hours after different treatments (n = 3). (K) HSCs were treated with CM from RAW 264.7 cells stimulated by various concentrations of GelMA hydrogel for 24 hours. Subsequently, total collagen was quantified using Sirius Red assay (n = 3). (L) Mechanical strength of HSC-T6 cells treated with CM from RAW 264.7 cells stimulated by various concentrations of GelMA hydrogel for 24 hours. GAPDH, glyceraldehyde phosphate dehydrogenase.
Fig. 2. Reveal of the ECM-cell-ECM vicious circle. (A) Mechanical strength and photograph of liver tissues with/without liver fibrosis. (B) Three-dimensional surface plots display surface hardness uniformity of hydrogels. (C) The response of macrophages to changes in matrix stiffness through a cycle of ECM-cell-ECM. Mechanism mechanics induce influx of Ca2+, mitochondrial damage, STING pathway activation, secretion of proinflammatory factors, HSC activation, and further resulting enhancement of matrix stiffness. (D) Approach to model the in vitro matrix mechanical environment. (E) Microphotographs of intracellular Ca2+ production of RAW 264.7 cells after treatments with various concentrations of GelMA hydrogel for 24 hours and (F) mean fluorescence intensity (MFI) of intracellular Ca2+ were analyzed using ImageJ software. (G) Mitochondrial membrane potentials of RAW 264.7 cells treated with various concentrations of GelMA hydrogel for 24 hours and (H) MFI of mitochondrial membrane potentials in RAW 264.7 were analyzed using ImageJ software. (I) Western blot detection of STING, TBK1, IRF3, p-STING, p-TBK1, and p-IRF3 in RAW 264.7 cells subjected to various concentrations of GelMA hydrogel treatments. (J) ELISA assay for extracellular secretion of TNF-α, IL-6, and IFN-β by RAW 264.7 cells at 24 hours after different treatments (n = 3). (K) HSCs were treated with CM from RAW 264.7 cells stimulated by various concentrations of GelMA hydrogel for 24 hours. Subsequently, total collagen was quantified using Sirius Red assay (n = 3). (L) Mechanical strength of HSC-T6 cells treated with CM from RAW 264.7 cells stimulated by various concentrations of GelMA hydrogel for 24 hours. GAPDH, glyceraldehyde phosphate dehydrogenase.CC BY · PubMed Central
Fig. 3. Synthesis and characterization of carrier-free nanosystems. (A) Particle sizes and zeta potentials of I, IC, ICM, ICMA, and ICMA@CZ; the zeta potential of MMs used as a control. (B) TEM images of I, IC, ICM, and ICMA@CZ. (C) SDS–polyacrylamide gel electrophoresis protein analysis of macrophage cell membrane. Samples were stained with Coomassie Blue. I) source macrophage cell membrane, II) MMs, III) IC, IV) ICM, and V) ICMA. (D) Absorbance of ICM, ICMA, and ICMA@CZ after incubation with varying ratios of BSA for 1 hour. (E) ICM, ICMA, and ICMA@CZ absorbance at 350 nm after different incubation times with 4% BSA. (F) Microphotographs of four cell lines including RAW 264.7, KC, HSC-T6, and LX-2 after incubation for 1 hour with IC, ICM, ICMA, and ICMA@CZ. Scale bar, 20 μm. (G) Flow cytometry analysis of fluorescence intensities inside four cells after treated by different samples for 1 hour and MFI were analyzed using FlowJo software. The concentration of ICG was fixed at 2 μg ml−1. a.u., arbitrary units.
Fig. 3. Synthesis and characterization of carrier-free nanosystems. (A) Particle sizes and zeta potentials of I, IC, ICM, ICMA, and ICMA@CZ; the zeta potential of MMs used as a control. (B) TEM images of I, IC, ICM, and ICMA@CZ. (C) SDS–polyacrylamide gel electrophoresis protein analysis of macrophage cell membrane. Samples were stained with Coomassie Blue. I) source macrophage cell membrane, II) MMs, III) IC, IV) ICM, and V) ICMA. (D) Absorbance of ICM, ICMA, and ICMA@CZ after incubation with varying ratios of BSA for 1 hour. (E) ICM, ICMA, and ICMA@CZ absorbance at 350 nm after different incubation times with 4% BSA. (F) Microphotographs of four cell lines including RAW 264.7, KC, HSC-T6, and LX-2 after incubation for 1 hour with IC, ICM, ICMA, and ICMA@CZ. Scale bar, 20 μm. (G) Flow cytometry analysis of fluorescence intensities inside four cells after treated by different samples for 1 hour and MFI were analyzed using FlowJo software. The concentration of ICG was fixed at 2 μg ml−1. a.u., arbitrary units.CC BY · PubMed Central
Fig. 4. Matrix mechanical remodeling through ECM degradation mediated by carrier-free nanosystems. (A) Approach to in vitro analysis of the interactions between matrix mechanics mediated ECM and endocytosis of nanoparticles. (B) Microphotographs of RAW 264.7 with adding of ICMA or ICMA@CZ for 2 hours after cocultured with HSC-T6 cells using a transwell plate. The HSC-T6 cells were pretreated with/without the CM from RAW 264.7 cells with/without stimulation of hydrogels (0.1 to 5 kPa) for 24 hours. Scale bar, 20 μm. (C) Approach to in vitro analysis of the ability of ICMA@CZ to degrade ECM. (D) Microphotographs of RAW 264.7 with adding of ICMA or ICMA@CZ for 2 hours after cocultured with HSC-T6 and LX-2 cells. The HSC-T6 and LX-2 cells were treated with/without the CM from RAW 264.7 cells with or without stimulation of LPS for 24 hours. Scale bar, 20 μm. (E) Confocal laser scanning microscopy (CLSM) images of α-SMA in HSC-T6 cells with/without adding of ICMA or ICMA@CZ for 2 hours. HSC-T6 cells were pretreated with/without the CM of RAW 264.7 cells stimulated with/without LPS for 24 hours. (F) Total collagen of HSC-T6 cells treated with different formulations was quantified using Sirius Red assay (n = 3). (G) CLSM images and (H) flow cytometry analysis of markers for M1 and M2 phenotypes in the polarization of RAW 264.7 macrophages before and after treatment with different samples for 2 hours. Green (CD86) and red (CD206). Scale bar, 10 μm. The concentration of nanoparticles was fixed at 2 μg/ml. (I) Mechanical strength of HSC-T6 cells treated with CM from RAW 264.7 cells stimulated by various concentrations of GelMA hydrogel for 24 hours before and after addition of ICMA@CZ. ns, not significant; DAPI, 4′,6-diamidino-2-phenylindole.
Fig. 4. Matrix mechanical remodeling through ECM degradation mediated by carrier-free nanosystems. (A) Approach to in vitro analysis of the interactions between matrix mechanics mediated ECM and endocytosis of nanoparticles. (B) Microphotographs of RAW 264.7 with adding of ICMA or ICMA@CZ for 2 hours after cocultured with HSC-T6 cells using a transwell plate. The HSC-T6 cells were pretreated with/without the CM from RAW 264.7 cells with/without stimulation of hydrogels (0.1 to 5 kPa) for 24 hours. Scale bar, 20 μm. (C) Approach to in vitro analysis of the ability of ICMA@CZ to degrade ECM. (D) Microphotographs of RAW 264.7 with adding of ICMA or ICMA@CZ for 2 hours after cocultured with HSC-T6 and LX-2 cells. The HSC-T6 and LX-2 cells were treated with/without the CM from RAW 264.7 cells with or without stimulation of LPS for 24 hours. Scale bar, 20 μm. (E) Confocal laser scanning microscopy (CLSM) images of α-SMA in HSC-T6 cells with/without adding of ICMA or ICMA@CZ for 2 hours. HSC-T6 cells were pretreated with/without the CM of RAW 264.7 cells stimulated with/without LPS for 24 hours. (F) Total collagen of HSC-T6 cells treated with different formulations was quantified using Sirius Red assay (n = 3). (G) CLSM images and (H) flow cytometry analysis of markers for M1 and M2 phenotypes in the polarization of RAW 264.7 macrophages before and after treatment with different samples for 2 hours. Green (CD86) and red (CD206). Scale bar, 10 μm. The concentration of nanoparticles was fixed at 2 μg/ml. (I) Mechanical strength of HSC-T6 cells treated with CM from RAW 264.7 cells stimulated by various concentrations of GelMA hydrogel for 24 hours before and after addition of ICMA@CZ. ns, not significant; DAPI, 4′,6-diamidino-2-phenylindole.CC BY · PubMed Central
Fig. 5. Matrix mechanical remodeling via STING alkylation mediated by carrier-free nanosystem. (A) ICMA@CZ remodeled ECM mechanical microenvironment through inhibiting cGAS-STING pathway in vitro. (B) Western blot and protein levels of (C) p-STING, p-IRF3, and p-TBK1 in RAW 264.7 cells quantified by densitometry and normalized by GAPDH levels (n = 3) after different treatments. I: RAW 264.7 cells; II: RAW 264.7 + LPS; III: RAW 264.7 + DMXAA; IV: RAW 264.7 + I + LPS; V: RAW 264.7 + IC + LPS; VI: RAW 264.7 + ICM + LPS; VII: RAW 264.7 + ICMA + LPS; VIII: RAW 264.7 + ICMA@CZ + LPS. (D) Representative Western blotting analysis of STING, TBK1, and IRF3 and phosphorylation of related proteins, which were extracted from RAW 264.7 cells after different treatments. I: RAW 264.7 + 30% hydrogel; II: RAW 264.7 + ICMA@CZ + 30% hydrogel. (E) Production of TNF-α, IL-6, and IFN-β [detected by enzyme-linked immunosorbent assay (ELISA)] in culture media in response to RAW 264.7 cells stimulated by exposure to the various conditions. Value represents mean and SD (n = 3). (F) Approach to in vitro analysis of the ability of ICMA@CZ to remodel the ECM mechanical microenvironment through inhibiting the STING pathway, and HSC-T6 cells were treated with/without CM from RAW 264.7 pretreated with/without different nanosystems for 2 hours and then stimulated with hydrogels for 24 hours; after that, total collagen was quantified using Sirius Red assay (n = 3), and quiescent HSC-T6 cells were used as a control. Differences between groups were statistically significant. Data were analyzed using the Student’s t test (****P < 0.0001 versus HSC-T6 or IC group and *P < 0.05 versus HSC-T6 group).
Fig. 5. Matrix mechanical remodeling via STING alkylation mediated by carrier-free nanosystem. (A) ICMA@CZ remodeled ECM mechanical microenvironment through inhibiting cGAS-STING pathway in vitro. (B) Western blot and protein levels of (C) p-STING, p-IRF3, and p-TBK1 in RAW 264.7 cells quantified by densitometry and normalized by GAPDH levels (n = 3) after different treatments. I: RAW 264.7 cells; II: RAW 264.7 + LPS; III: RAW 264.7 + DMXAA; IV: RAW 264.7 + I + LPS; V: RAW 264.7 + IC + LPS; VI: RAW 264.7 + ICM + LPS; VII: RAW 264.7 + ICMA + LPS; VIII: RAW 264.7 + ICMA@CZ + LPS. (D) Representative Western blotting analysis of STING, TBK1, and IRF3 and phosphorylation of related proteins, which were extracted from RAW 264.7 cells after different treatments. I: RAW 264.7 + 30% hydrogel; II: RAW 264.7 + ICMA@CZ + 30% hydrogel. (E) Production of TNF-α, IL-6, and IFN-β [detected by enzyme-linked immunosorbent assay (ELISA)] in culture media in response to RAW 264.7 cells stimulated by exposure to the various conditions. Value represents mean and SD (n = 3). (F) Approach to in vitro analysis of the ability of ICMA@CZ to remodel the ECM mechanical microenvironment through inhibiting the STING pathway, and HSC-T6 cells were treated with/without CM from RAW 264.7 pretreated with/without different nanosystems for 2 hours and then stimulated with hydrogels for 24 hours; after that, total collagen was quantified using Sirius Red assay (n = 3), and quiescent HSC-T6 cells were used as a control. Differences between groups were statistically significant. Data were analyzed using the Student’s t test (****P < 0.0001 versus HSC-T6 or IC group and *P < 0.05 versus HSC-T6 group).CC BY · PubMed Central
Fig. 6. In vivo antifibrosis efficiency and matrix mechanical remodeling ability of carrier-free nanosystems. (A) Ex vivo fluorescence imaging of major organs after intravenously injection of ICMA@CZ for 12 and 24 hours. (B) Ex vivo quantification of fluorescence distribution in major organs at 12 and 24 hours (n = 3, mean ± SD). (C) Schematic representation of the CCl4-induced liver fibrosis model and treatment timeline for PBS, IC, ICM, ICMA, or ICMA@CZ nanosystem therapy. ip, intraperitoneal; iv, intravenous. (D) Liver injury characterization by serum AST and ALT in mice from the PBS, IC, ICM, ICMA, or ICMA@CZ nanosystem treatment groups (n = 6). (E) Representative hematoxylin and eosin (H&E) staining and immunofluorescence staining of Sirius Red in CCl4-induced fibrotic livers from the PBS, IC, ICM, ICMA, or ICMA@CZ nanosystem treatment groups. Scale bar, 100 μm. (F) Quantification analysis of fibrosis in CCl4-induced fibrotic livers from the PBS, IC, ICM, ICMA or ICMA@CZ nanosystem treatment groups was performed by ImageJ. (G) Relative mRNA expression of collagen I in CCl4-induced fibrotic livers from the PBS, IC, ICM, ICMA, or ICMA@CZ nanosystem treatment groups (n = 6). Healthy mice used as control. (H) Mechanical strength of livers after different treatments. Healthy liver used as control. Data were analyzed using Student’s t test (****P < 0.0001 versus PBS group).
Fig. 6. In vivo antifibrosis efficiency and matrix mechanical remodeling ability of carrier-free nanosystems. (A) Ex vivo fluorescence imaging of major organs after intravenously injection of ICMA@CZ for 12 and 24 hours. (B) Ex vivo quantification of fluorescence distribution in major organs at 12 and 24 hours (n = 3, mean ± SD). (C) Schematic representation of the CCl4-induced liver fibrosis model and treatment timeline for PBS, IC, ICM, ICMA, or ICMA@CZ nanosystem therapy. ip, intraperitoneal; iv, intravenous. (D) Liver injury characterization by serum AST and ALT in mice from the PBS, IC, ICM, ICMA, or ICMA@CZ nanosystem treatment groups (n = 6). (E) Representative hematoxylin and eosin (H&E) staining and immunofluorescence staining of Sirius Red in CCl4-induced fibrotic livers from the PBS, IC, ICM, ICMA, or ICMA@CZ nanosystem treatment groups. Scale bar, 100 μm. (F) Quantification analysis of fibrosis in CCl4-induced fibrotic livers from the PBS, IC, ICM, ICMA or ICMA@CZ nanosystem treatment groups was performed by ImageJ. (G) Relative mRNA expression of collagen I in CCl4-induced fibrotic livers from the PBS, IC, ICM, ICMA, or ICMA@CZ nanosystem treatment groups (n = 6). Healthy mice used as control. (H) Mechanical strength of livers after different treatments. Healthy liver used as control. Data were analyzed using Student’s t test (****P < 0.0001 versus PBS group).CC BY · PubMed Central
Fig. 7. In vivo ECM-cell-ECM closed-loop reversal of liver fibrosis. (A) Immunofluorescence staining of p-STING in livers from the PBS, IC, ICM, ICMA, and ICMA@CZ treatment groups. Scale bar, 100 μm. (B) Representative Western blotting analysis of STING, TBK1, and IRF3 and phosphorylation of related proteins, which were extracted from livers after different treatments. I: healthy; II: PBS; III: IC; IV: ICM; V: ICMA; VI: ICMA@CZ. (C) Immunofluorescence staining of CD68 in livers from the PBS, IC, ICM, ICMA, and ICMA@CZ treatment groups. Scale bar, 100 μm. (D) Representative flow cytometry plots of macrophage polarization (CD86+ and CD206+ cells). (E) Relative mRNA expression of TNF-α, IFN-β, and IL-6 from the PBS, IC, ICM, ICMA, and ICMA@CZ treatment groups (n = 6). Data were analyzed using the Student’s t test (****P < 0.0001 versus PBS group). (F) Immunofluorescence staining of α-SMA in livers from the PBS, IC, ICM, ICMA, and ICMA@CZ treatment groups. Scale bar, 100 μm. (G) Western blot analysis of α-SMA expression after PBS, IC, ICM, ICMA, and ICMA@CZ treatment in fibrotic livers. Healthy mice used as control.
Fig. 7. In vivo ECM-cell-ECM closed-loop reversal of liver fibrosis. (A) Immunofluorescence staining of p-STING in livers from the PBS, IC, ICM, ICMA, and ICMA@CZ treatment groups. Scale bar, 100 μm. (B) Representative Western blotting analysis of STING, TBK1, and IRF3 and phosphorylation of related proteins, which were extracted from livers after different treatments. I: healthy; II: PBS; III: IC; IV: ICM; V: ICMA; VI: ICMA@CZ. (C) Immunofluorescence staining of CD68 in livers from the PBS, IC, ICM, ICMA, and ICMA@CZ treatment groups. Scale bar, 100 μm. (D) Representative flow cytometry plots of macrophage polarization (CD86+ and CD206+ cells). (E) Relative mRNA expression of TNF-α, IFN-β, and IL-6 from the PBS, IC, ICM, ICMA, and ICMA@CZ treatment groups (n = 6). Data were analyzed using the Student’s t test (****P < 0.0001 versus PBS group). (F) Immunofluorescence staining of α-SMA in livers from the PBS, IC, ICM, ICMA, and ICMA@CZ treatment groups. Scale bar, 100 μm. (G) Western blot analysis of α-SMA expression after PBS, IC, ICM, ICMA, and ICMA@CZ treatment in fibrotic livers. Healthy mice used as control.CC BY · PubMed Central

Verification

Claims the paper makes

19 Valid · 2 Not valid · 6 Not checked · 98 Own results and interpretations

60 more claims

Create a free account to see all 125 claims and to verify the 3 references still open.

See all claims — free account
  • Probably not a substantial claim. 13
  • It may state two separate claims as one. 50

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 48 references

Cited by

Metadata

Authors
Han, H., Yu, D., Liu, Y., Jia, H., & Liu, W.
Affiliations
Tianjin University (CN)
Corresponding author
Jia, Huizhen
Venue
Science Advances
Published
2025-11-21
Volume
11
Issue
47
Pages
eadz4126-eadz4126
ISSN
2375-2548 (ISSN-L)
OpenAlex
W4416368410
Cited by
7
References
47
Citations by year
2026: 7
FWCI
3.88
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Science Advances (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
National Natural Science Foundation of China (52273146)
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Keywords
liver fibrosis, STING pathway, macrophages, extracellular matrix stiffness, hepatic stellate cells, matrix metalloproteinases, extracellular matrix degradation, antifibrotic therapy
MeSH terms
STING Protein, Alkylation, Animals, Disease Models, Animal, Extracellular Matrix, Humans, Liver Cirrhosis, Macrophages, Male, Membrane Proteins, Signal Transduction, Mice, Hepatic Stellate Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.